Please login to the form below

Not currently logged in
Email:
Password:

mCNV

This page shows the latest mCNV news and features for those working in and with pharma, biotech and healthcare.

Lucentis claims speedy FDA review for myopia complication

Lucentis claims speedy FDA review for myopia complication

Eylea is not yet approved for mCNV in the US, although Bayer has a green light for this use in Europe and so is already competing head-to-head with Novartis

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics